Frauke Zipp
Frauke Zipp
Professor of Neurology, University Medical Center of the Johannes Gutenberg
Bestätigte E-Mail-Adresse bei - Startseite
Zitiert von
Zitiert von
Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis
Nature 476 (7359), 214-219, 2011
Analysis of immune-related loci identifies 48 new susceptibility variants for multiple sclerosis
International IBD Genetics Consortium (IIBDGC), C Agliardi, L Alfredsson, ...
Nature genetics 45 (11), 1353-1360, 2013
Multiple Sclerosis Severity Score: using disability and disease duration to rate disease severity
R Roxburgh, SR Seaman, T Masterman, AE Hensiek, SJ Sawcer, ...
Neurology 64 (7), 1144-1151, 2005
ECTRIMS/EAN guideline on the pharmacological treatment of people with multiple sclerosis
X Montalban, R Gold, AJ Thompson, S Otero-Romero, MP Amato, ...
Multiple Sclerosis Journal 24 (2), 96-120, 2018
Multiple sclerosis genomic map implicates peripheral immune cells and microglia in susceptibility
International Multiple Sclerosis Genetics Consortium*†, ANZgene, ...
Science 365 (6460), eaav7188, 2019
Genetic cell ablation reveals clusters of local self-renewing microglia in the mammalian central nervous system
J Bruttger, K Karram, S Wörtge, T Regen, F Marini, N Hoppmann, M Klein, ...
Immunity 43 (1), 92-106, 2015
Comprehensive research synopsis and systematic meta-analyses in Parkinson's disease genetics: The PDGene database
CM Lill, JT Roehr, MB McQueen, FK Kavvoura, S Bagade, BMM Schjeide, ...
PLoS genetics 8 (3), e1002548, 2012
Sirt1 contributes critically to the redox-dependent fate of neural progenitors
T Prozorovski, U Schulze-Topphoff, R Glumm, J Baumgart, F Schröter, ...
Nature cell biology 10 (4), 385-394, 2008
The brain as a target of inflammation: common pathways link inflammatory and neurodegenerative diseases
F Zipp, O Aktas
Trends in neurosciences 29 (9), 518-527, 2006
Green tea epigallocatechin-3-gallate mediates T cellular NF-κB inhibition and exerts neuroprotection in autoimmune encephalomyelitis
O Aktas, T Prozorovski, A Smorodchenko, NE Savaskan, R Lauster, ...
The Journal of Immunology 173 (9), 5794-5800, 2004
Mechanisms of disease: aquaporin-4 antibodies in neuromyelitis optica
S Jarius, F Paul, D Franciotta, P Waters, F Zipp, R Hohlfeld, A Vincent, ...
Nature Clinical Practice Neurology 4 (4), 202-214, 2008
Human brain-cell death induced by tumour-necrosis-factor-related apoptosis-inducing ligand (TRAIL)
R Nitsch, I Bechmann, RA Deisz, D Haas, TN Lehmann, U Wendling, ...
The Lancet 356 (9232), 827-828, 2000
Treatment of relapsing paralysis in experimental encephalomyelitis by targeting Th1 cells through atorvastatin
O Aktas, S Waiczies, A Smorodchenko, J Dörr, B Seeger, T Prozorovski, ...
The Journal of experimental medicine 197 (6), 725-733, 2003
Class II HLA interactions modulate genetic risk for multiple sclerosis
Nature genetics 47 (10), 1107-1113, 2015
In vivo imaging of partially reversible th17 cell-induced neuronal dysfunction in the course of encephalomyelitis
V Siffrin, H Radbruch, R Glumm, R Niesner, M Paterka, J Herz, ...
Immunity 33 (3), 424-436, 2010
MR-elastography reveals degradation of tissue integrity in multiple sclerosis
J Wuerfel, F Paul, B Beierbach, U Hamhaber, D Klatt, S Papazoglou, ...
Neuroimage 49 (3), 2520-2525, 2010
Indolamine 2, 3‐dioxygenase is expressed in the CNS and down‐regulates autoimmune inflammation
E Kwidzinski, J Bunse, O Aktas, D Richter, L Mutlu, F Zipp, R Nitsch, ...
The FASEB Journal 19 (10), 1347-1349, 2005
Immunoneuropsychiatry—novel perspectives on brain disorders
K Pape, R Tamouza, M Leboyer, F Zipp
Nature Reviews Neurology 15 (6), 317-328, 2019
Neuronal damage in brain inflammation
O Aktas, O Ullrich, C Infante-Duarte, R Nitsch, F Zipp
Archives of neurology 64 (2), 185-189, 2007
Neuronal damage in autoimmune neuroinflammation mediated by the death ligand TRAIL
O Aktas, A Smorodchenko, S Brocke, C Infante-Duarte, US Topphoff, ...
Neuron 46 (3), 421-432, 2005
Das System kann den Vorgang jetzt nicht ausführen. Versuchen Sie es später erneut.
Artikel 1–20